title: Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report.
authors.affiliation: Hospital for Children and Adolescents, University of Helsinki, Finland. liisa.hovi@hus.fi
authors.forename: L
authors.initials: L
authors.lastname: Hovi
authors.forename: S
authors.initials: S
authors.lastname: Wikström
authors.forename: K
authors.initials: K
authors.lastname: Vettenranta
authors.forename: P
authors.initials: P
authors.lastname: Heikkilä
authors.forename: U M
authors.initials: UM
authors.lastname: Saarinen-Pihkala
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000401:mortality; D018268:Adrenocortical Carcinoma / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male
chemical_list: D005047:Etoposide; D002945:Cisplatin